Memantine LEK
Country: Unjoni Ewropea
Lingwa: Bulgaru
Sors: EMA (European Medicines Agency)
Fuljett ta 'informazzjoni
(PIL)
16-11-2020
Karatteristiċi tal-prodott
(SPC)
16-11-2020
Rapport ta 'Valutazzjoni Pubblika
(PAR)
29-04-2013
Ingredjent attiv:
мемантин хидрохлорид
Disponibbli minn:
Pharmathen S.A.
Kodiċi ATC:
N06DX01
INN (Isem Internazzjonali):
memantine
Grupp terapewtiku:
Psychoanaleptics и други анти-деменция лекарства
Żona terapewtika:
Болест на Алцхаймер
Indikazzjonijiet terapewtiċi:
Лечение на пациенти с умерена до тежка болест на Алцхаймер.
Sommarju tal-prodott:
Revision: 5
L-istatus ta 'awtorizzazzjoni:
упълномощен
Data ta 'l-awtorizzazzjoni:
2013-04-21
Fuljett ta 'informazzjoni
Skip to main content [European Medicines Agency]
Menu *
EMA WEBSITE TEMPORARILY UNAVAILABLE
This website is currently unavailable due to essential maintenance.
EMERGENCY CONTACT DETAILS
To report a potentially serious problem with a centrally authorised
medicine, call our product emergency hotline on +31 (0)88 781 7600.
To report a product quality defect, including a suspected defect, of a
centrally authorised medicine that could result in a recall or
abnormal restriction on supply, marketing or manufacturing
authorisation holders can call +31 (0)65 008 9457 outside business
hours.
The details of your call may be documented, including personal data if
you provide them (such as your name, contact details and nature of the
issue raised), in accordance with our privacy statement. You can
consult our privacy statement at
https://www.ema.europa.eu/en/about-us/legal/general-privacy-statement
[/en/about-us/legal/general-privacy-statement] once the website is
back online.
RSS feed Twitter YouTube LinkedIn
© 1995-2020 European Medicines Agency
European Union agencies network [European Union agencies network]
An agency of the European Union [European Union flag]
Aqra d-dokument sħiħ
Karatteristiċi tal-prodott
Skip to main content [European Medicines Agency]
Menu *
EMA WEBSITE TEMPORARILY UNAVAILABLE
This website is currently unavailable due to essential maintenance.
EMERGENCY CONTACT DETAILS
To report a potentially serious problem with a centrally authorised
medicine, call our product emergency hotline on +31 (0)88 781 7600.
To report a product quality defect, including a suspected defect, of a
centrally authorised medicine that could result in a recall or
abnormal restriction on supply, marketing or manufacturing
authorisation holders can call +31 (0)65 008 9457 outside business
hours.
The details of your call may be documented, including personal data if
you provide them (such as your name, contact details and nature of the
issue raised), in accordance with our privacy statement. You can
consult our privacy statement at
https://www.ema.europa.eu/en/about-us/legal/general-privacy-statement
[/en/about-us/legal/general-privacy-statement] once the website is
back online.
RSS feed Twitter YouTube LinkedIn
© 1995-2020 European Medicines Agency
European Union agencies network [European Union agencies network]
An agency of the European Union [European Union flag]
Aqra d-dokument sħiħ
